Find Risk Clinical Trials in New York, New York – 33 Enrolling Now

Showing 1–20 of 33 trials

Recruiting

Phase 3

Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer

Intermediate Risk Non-Muscle Invasive Bladder Cancer

Ferring Pharmaceuticals454 enrolled94 locationsNCT06510374

Recruiting

Digital Strategies to Advance Help-Seeking Aim 1 and 2

Early PsychosisFirst-episode PsychosisClinical High Risk

Columbia University25,000 enrolled1 locationNCT06774430

Recruiting

Phase 1Phase 2

Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression

Acute Lymphoblastic LeukaemiaHigher Risk Myelodysplastic SyndromesAcute Myeloid Leukaemia

AstraZeneca84 enrolled30 locationsNCT07155226

Recruiting

Phase 2

Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC

High-risk Non-muscle Invasive Bladder Cancer

CG Oncology, Inc.325 enrolled65 locationsNCT06567743

Recruiting

Phase 2

A Study of a Vaccine in Combination With Beta-glucan in People With Neuroblastoma

NeuroblastomaHigh Risk NeuroblastomaMetastatic Neuroblastoma

Memorial Sloan Kettering Cancer Center94 enrolled7 locationsNCT06057948

Recruiting

Phase 1Phase 2

A Study Exploring Changes in a Variety of Biomarkers Following Dosing With MT1988 in Participants at Clinical High Risk for Psychosis

Clinical High Risk for Psychosis (CHR)

Monument Therapeutics Limited150 enrolled15 locationsNCT07226895

Recruiting

Phase 2

Neoadjuvant ADT + Darolutamide With Pembrolizumab, Followed by Adjuvant Pembrolizumab in Molecularly Stratified High-Risk Prostate Cancer

Prostate CancerHigh-risk Prostate Cancer

Icahn School of Medicine at Mount Sinai40 enrolled1 locationNCT07027124

Recruiting

Phase 1

A Study of CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias

Chronic Myeloid LeukemiaHigh Risk Myelodysplastic SyndromeChronic Myelomonocytic Leukemia (CMML)+1 more

Crossbow Therapeutics, Inc.72 enrolled11 locationsNCT06994676

Recruiting

Phase 2

Immunoprevention for High-risk Lung Lesions

High-risk Lung Nodules

Robert Samstein59 enrolled1 locationNCT07284485

Recruiting

Phase 3

Study to Compare Axicabtagene Ciloleucel With Standard of Care Therapy as First-line Treatment in Participants With High-risk Large B-cell Lymphoma

High-risk Large B-cell Lymphoma (LBCL)

Kite, A Gilead Company300 enrolled90 locationsNCT05605899

Recruiting

Phase 2

N10: A Study of Reduced Chemotherapy and Monoclonal Antibody (mAb)-Based Therapy in Children With Neuroblastoma

NeuroblastomaHigh Risk NeuroblastomaChildhood Neuroblastoma

Memorial Sloan Kettering Cancer Center45 enrolled1 locationNCT06528496

Recruiting

Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)

Blood PressureNeuropathyDiabetes+6 more

Jaeb Center for Health Research200 enrolled18 locationsNCT06837181

Recruiting

Phase 2

Study of Neoadjuvant PARP Inhibition Followed by Radical Prostatectomy in Patients With Unfavorable Intermediate-Risk or High-Risk Prostate Cancer With Select HRR Gene Alterations

Prostate CancerBRCA1 MutationBRCA2 Mutation+2 more

Rana McKay, MD32 enrolled6 locationsNCT05498272

Recruiting

MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs)

Primary myelofibrosis (PMF)Myeloproliferative DisordersMyelofibrosis+49 more

MPN Research Foundation5,000 enrolled2 locationsNCT07362225

Recruiting

Phase 4

DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Treatment of Gestational Diabetes

Pregnancy, High RiskGestational Diabetes Mellitus

Ohio State University1,572 enrolled21 locationsNCT06445946

Recruiting

Not Applicable

Cryopreservation of Ovarian Tissue

CancerFertility PreservationRisk of Premature Ovarian Failure

Weill Medical College of Cornell University300 enrolled1 locationNCT01558544

Recruiting

Not Applicable

Pivotal, Prospective, Multi-centre, Single-arm Study to Evaluate the Safety and Effectiveness of Oli for Identification of Patients, During the Intrapartum Period, Who Are at Higher Risk of Developing Abnormal Postpartum Uterine Bleeding, Including Postpartum Haemorrhage

High Risk PregnancyMaternal Care PatternsPost partum haemorrhage

Baymatob Operations Pty Ltd1,000 enrolled7 locationsNCT06655207

Recruiting

Risk Clinical Trials in New York, New York

Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer

Digital Strategies to Advance Help-Seeking Aim 1 and 2

Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression

Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC

A Study of a Vaccine in Combination With Beta-glucan in People With Neuroblastoma

A Study Exploring Changes in a Variety of Biomarkers Following Dosing With MT1988 in Participants at Clinical High Risk for Psychosis

Neoadjuvant ADT + Darolutamide With Pembrolizumab, Followed by Adjuvant Pembrolizumab in Molecularly Stratified High-Risk Prostate Cancer

A Study of CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias

Immunoprevention for High-risk Lung Lesions

Study to Compare Axicabtagene Ciloleucel With Standard of Care Therapy as First-line Treatment in Participants With High-risk Large B-cell Lymphoma

N10: A Study of Reduced Chemotherapy and Monoclonal Antibody (mAb)-Based Therapy in Children With Neuroblastoma

Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)

Study of Neoadjuvant PARP Inhibition Followed by Radical Prostatectomy in Patients With Unfavorable Intermediate-Risk or High-Risk Prostate Cancer With Select HRR Gene Alterations

MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs)

DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Treatment of Gestational Diabetes

Cryopreservation of Ovarian Tissue

Pivotal, Prospective, Multi-centre, Single-arm Study to Evaluate the Safety and Effectiveness of Oli for Identification of Patients, During the Intrapartum Period, Who Are at Higher Risk of Developing Abnormal Postpartum Uterine Bleeding, Including Postpartum Haemorrhage

T1D Pregnancy & Me

Study of REM-422 in Patients With AML or Higher Risk MDS

GD2-SADA:177Lu-DOTA Complex in Patients With Solid Tumors Known to Express GD2